Detalhe da pesquisa
1.
Cholangitis and Interruptions of Neoadjuvant Chemotherapy Associate with Reduced Overall and Progression-Free Survival in Pancreatic Cancer.
Ann Surg Oncol
; 31(4): 2621-2631, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153645
2.
The impact of implementing current treatment modalities and female sex on gastric cancer outcomes, 2000-2016: a longitudinal nationwide cohort study.
Acta Oncol
; 62(12): 1732-1741, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750187
3.
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Cancer Immunol Immunother
; 71(2): 417-431, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216247
4.
C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients.
Acta Oncol
; 61(10): 1240-1247, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35905053
5.
Gallbladder cancer epidemiology, treatment and survival in Southern Finland - a population-based study.
Scand J Gastroenterol
; 56(8): 929-939, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224306
6.
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
Cancer
; 126(18): 4156-4167, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673417
7.
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 373(19): 1814-23, 2015 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26406150
8.
Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.
Acta Oncol
; 57(6): 799-806, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29241394
9.
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.
Lancet Oncol
; 17(7): 917-927, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27279544
10.
Sunitinib-induced hypertension, neutropaenia and thrombocytopaenia as predictors of good prognosis in patients with metastatic renal cell carcinoma.
BJU Int
; 117(1): 110-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25252180
11.
Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma.
Acta Oncol
; 53(1): 113-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23721300
12.
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032).
J Immunother Cancer
; 12(2)2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38316517
13.
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
Lancet Gastroenterol Hepatol
; 9(3): 205-217, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237621
14.
Safety, efficacy, and biological data of T cell-enabling oncolytic adenovirus TILT-123 in advanced solid cancers from the TUNIMO monotherapy phase I trial.
Clin Cancer Res
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546220
15.
Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.
J Clin Invest
; 133(6)2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719749
16.
Long-term nationwide trends in the treatment of and outcomes among pancreatic cancer patients.
Eur J Surg Oncol
; 48(5): 1087-1092, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844817
17.
Evolution and modulation of antigen-specific T cell responses in melanoma patients.
Nat Commun
; 13(1): 5988, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220826
18.
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer.
Cancer Treat Res Commun
; 28: 100405, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329846
19.
ODM-204, a Novel Dual Inhibitor of CYP17A1 and Androgen Receptor: Early Results from Phase I Dose Escalation in Men with Castration-resistant Prostate Cancer.
Eur Urol Focus
; 6(1): 63-70, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194031
20.
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours.
ESMO Open
; 5(6): e001081, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262202